Medifast, Inc.
Medifast, Inc. (MED) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
med · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Medifast, Inc. (MED) measures how much investors pay for each dollar of the company's trailing earnings. MED's current PE ratio of N/A is calculated by dividing its stock price of $12.10 by its TTM earnings per share of -$1.82.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 18 fiscal years · Front-end computedMinQ1 · 25%20.3x
MedianQ3 · 75%92.1x
Max
At N/A, MED's current P/E is lower than in 0% of its annual fiscal year readings over the past 18 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Personal Products & Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Medifast, Inc.You MED | $135M | N/A | — | -$1.82 |
 Robo.ai Inc. AIIO | $58M | N/A | — | -$10.59 |
 a.k.a. Brands Holding Corp. AKA | $95M | N/A | — | -$2.93 |
 Bassett Furniture Industries, Incorporated BSET | $123M | 22.10x | +76.1% | $0.70 |
 China Automotive Systems, Inc. CAAS | $134M | 3.00x | -76.1% | $1.42 |
 Clarus Corporation CLAR | $110M | N/A | — | -$1.21 |
 Torrid Holdings Inc. CURV | $163M | N/A | — | -$0.07 |
Industry Average 2 peers with valid PE | — | 12.55x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.70 | — | |
2024-12-31 FY2024 | 92.10x | $0.19 | +1151.5% | |
2023-12-31 FY2023 | 7.36x | $9.13 | -18.2% | |
2022-12-31 FY2022 | 8.99x | $12.82 | -39.8% | |
2021-12-31 FY2021 | 14.94x | $14.01 | -33.5% | |
2020-12-31 FY2020 | 22.47x | $8.74 | +35.7% | |
2019-12-31 FY2019 | 16.55x | $6.62 | -38.2% | |
2018-12-31 FY2018 | 26.77x | $4.67 | -10.8% | |
2017-12-31 FY2017 | 30.03x | $2.32 | +8.6% | |
2016-12-31 FY2016 | 27.64x | $1.51 | +52.6% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Medifast, Inc. (MED) measures how much investors pay for each dollar of the company's trailing earnings. MED's current PE ratio of N/A is calculated by dividing its stock price of $12.10 by its TTM earnings per share of -$1.82.
Frequently asked questions
MED pe ratio · 6 questionsMED's current PE ratio is N/A as of 2026-06-08, based on a stock price of $12.10 and TTM EPS of -$1.82. Data sourced from Financial Modeling Prep via MED's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medifast, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08